Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M GELFAND

Showing results (311-320 of 889) with videos related to

Pageof 89
Sort By:
British Journal of Cancer|May 1, 1975
Neoplastic fibroblasts sensitive to the growth inhibition by homologous cells but insensitive to inhibition by parent normal cellsO Y Pletyushkina, J M Vasiliev, I M Gelfand
Clinics in Dermatology|April 23, 2003
The epidemiology of atopic dermatitisRoss M Levy, Joel M Gelfand, Albert C Yan
The Journal of Pediatrics|December 2, 2006
Presentation and clinical progression of pseudohypoparathyroidism with multi-hormone resistance and Albright hereditary osteodystrophy: a case seriesInessa M Gelfand, Erica A Eugster, Linda A DiMeglio
The Journal of Investigative Dermatology|March 17, 2010
Psoriasis and cardiovascular risk: strength in numbersJoel M Gelfand, Rahat S Azfar, Nehal N Mehta
The Journal of Investigative Dermatology|April 16, 2011
Psoriasis and cardiovascular risk: strength in numbers, part IIJoel M Gelfand, Nehal N Mehta, Sinéad M Langan
JAMA Dermatology|November 17, 2020
Association Between Early Severe Cardiovascular Events and Ustekinumab Treatment?Joel M Gelfand, Erica D Dommasch, Nehal N Mehta
Journal of the American Academy of Dermatology|January 21, 2014
Counterpoint: A tale of two meta-analyses revisitedErica D Dommasch, Andrea B Troxel, Joel M Gelfand
Renal Physiology|January 1, 1981
Effects of glipizide on water and electrolyte handling in water-loaded humansH G Preuss, R Rodelas, A Terlinsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1998
Predicting amino acid sequences of the antibody human VH chains from its first several residuesB A Galitsky, I M Gelfand, A E Kister
JAMA Cardiology|September 18, 2024
Psoriasis and Atherosclerotic CV Disease-Risk Factor or Risk Marker?Michael S Garshick, Brittany N Weber, Joel M Gelfand
Pageof 89

Showing results (311-320 of 889) with videos related to

Sort By:
Pageof 89
British Journal of Cancer|May 1, 1975
Neoplastic fibroblasts sensitive to the growth inhibition by homologous cells but insensitive to inhibition by parent normal cellsO Y Pletyushkina, J M Vasiliev, I M Gelfand
Clinics in Dermatology|April 23, 2003
The epidemiology of atopic dermatitisRoss M Levy, Joel M Gelfand, Albert C Yan
The Journal of Pediatrics|December 2, 2006
Presentation and clinical progression of pseudohypoparathyroidism with multi-hormone resistance and Albright hereditary osteodystrophy: a case seriesInessa M Gelfand, Erica A Eugster, Linda A DiMeglio
The Journal of Investigative Dermatology|March 17, 2010
Psoriasis and cardiovascular risk: strength in numbersJoel M Gelfand, Rahat S Azfar, Nehal N Mehta
The Journal of Investigative Dermatology|April 16, 2011
Psoriasis and cardiovascular risk: strength in numbers, part IIJoel M Gelfand, Nehal N Mehta, Sinéad M Langan
JAMA Dermatology|November 17, 2020
Association Between Early Severe Cardiovascular Events and Ustekinumab Treatment?Joel M Gelfand, Erica D Dommasch, Nehal N Mehta
Journal of the American Academy of Dermatology|January 21, 2014
Counterpoint: A tale of two meta-analyses revisitedErica D Dommasch, Andrea B Troxel, Joel M Gelfand
Renal Physiology|January 1, 1981
Effects of glipizide on water and electrolyte handling in water-loaded humansH G Preuss, R Rodelas, A Terlinsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1998
Predicting amino acid sequences of the antibody human VH chains from its first several residuesB A Galitsky, I M Gelfand, A E Kister
JAMA Cardiology|September 18, 2024
Psoriasis and Atherosclerotic CV Disease-Risk Factor or Risk Marker?Michael S Garshick, Brittany N Weber, Joel M Gelfand
Pageof 89